HF
CPIX icon

Hoxton Financial’s Cumberland Pharmaceuticals CPIX Stock Holding History

Hoxton Financial’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-380
Closed -$2K – 381
2013
Q4 		$2K Buy
380
+112
+42% +$547 ﹤0.01% 628
2013
Q3 		$1K Buy
+268
New +$1.33K ﹤0.01% 431

Other funds holding CPIX

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
KIM
Kestrel Investment Management San Mateo, California $167M AUM 20.81% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GHA
GW Henssler & Associates Kennesaw, Georgia $2.12B AUM 20.77% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Hoxton Financial's CPIX Position: Q1 2014 in Review

Hoxton Financial sold out of Cumberland Pharmaceuticals (CPIX) in Q1 2014, closing a stake of 380 shares — an estimated $2K sold.

Hoxton Financial first reported a position in CPIX in Q3 2013 and held it in 2 quarters. The position peaked at $2K in Q4 2013. 47 funds tracked by Wall St. Rank hold CPIX as of Q1 2014.

  • Hoxton Financial reported no remaining Cumberland Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
  • Hoxton Financial sold 380 Cumberland Pharmaceuticals shares in Q1 2014, an estimated $2K.
  • Hoxton Financial first reported a position in Cumberland Pharmaceuticals in Q3 2013 and held it in 2 quarters.
  • Hoxton Financial's Cumberland Pharmaceuticals position peaked at $2K in Q4 2013.
  • 47 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2014.

Based on Hoxton Financial's 13F filing for Q1 2014, filed 25 Apr 2014.